We provide you with 20 years of free, institutional-grade data for ASLN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ASLN. Explore the full financial landscape of ASLN stock.
| Reported Date | CIK | Ticker | Type |
|---|
ASLAN Pharmaceuticals Limited(NASDAQ:ASLN) 
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatit...
Website: http://www.aslanpharma.com
Founded: 2010
IPO Price: $8.05 (Dec 03, 2019)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ASLN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.